Home/Filings/4/0001179110-14-002273
4//SEC Filing

OSIRIS THERAPEUTICS, INC. 4

Accession 0001179110-14-002273

CIK 0001360886operating

Filed

Feb 6, 7:00 PM ET

Accepted

Feb 7, 9:33 AM ET

Size

6.0 KB

Accession

0001179110-14-002273

Insider Transaction Report

Form 4
Period: 2014-02-06
FRIEDLI PETER
Director10% OwnerOther
Transactions
  • Award

    Common Stock

    2014-02-06$14.93/sh+10,000$149,30010,204,404 total
Holdings
  • Common Stock

    (indirect: See Note 2)
    4,606,051
Footnotes (2)
  • [F1]Grant of 10,000 shares of common stock of the Registrant as compensation for services as a member of the Board of Directors during the fiscal year ended December 31, 2013, made under the Amended and Restated 2006 Omnibus Plan.
  • [F2]The Reporting Person holds indirect beneficial ownership of 4,103,301 shares of common stock held by Venturetec, Inc., 500,000 shares held by his minor daughter and 2,750 shares held by his spouse. The Reporting Person holds approximately a 21% interest in Venturetec, Inc. and serves as its president. The Reporting Person disclaims beneficial ownership in the shares held by his daughter and spouse and disclaims beneficial interest in the shares held by Venturetec, Inc., beyond the extent of his pecuniary interest therein.

Issuer

OSIRIS THERAPEUTICS, INC.

CIK 0001360886

Entity typeoperating
IncorporatedMD

Related Parties

1
  • filerCIK 0001360886

Filing Metadata

Form type
4
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 9:33 AM ET
Size
6.0 KB